Cargando…
Amarogentin promotes osteoblast differentiation in oestrogen-deficiency-induced osteoporosis rats by modulating the Nrf-2/MAPK/ERK signalling pathway
INTRODUCTION: The beneficial effect of amarogentin in the management of osteoporosis was determined using in vivo and in vitro methods. MATERIAL AND METHODS: Experimental osteoporosis was induced in rats via bilateral ovariectomy. Rats were then treated for 5 weeks with amarogentin (50 and 100 mg/kg...
Autores principales: | Li, Sirui, Li, Xianlong, He, Feng, Jiao, Rui, Zhang, Song, Li, Zhihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074178/ https://www.ncbi.nlm.nih.gov/pubmed/37034504 http://dx.doi.org/10.5114/aoms.2019.89652 |
Ejemplares similares
-
Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLCγ2-PKC and MAPK Pathways
por: Yen, Ting-Lin, et al.
Publicado: (2014) -
Amarogentin Displays Immunomodulatory Effects in Human Mast Cells and Keratinocytes
por: Wölfle, Ute, et al.
Publicado: (2015) -
Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice
por: Zhang, Ya, et al.
Publicado: (2017) -
α-Asarone Attenuates Osteoclastogenesis and Prevents Against Oestrogen-Deficiency Induced Osteoporosis
por: Tian, Hao, et al.
Publicado: (2022) -
Effects of irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 inflammasome
por: Xu, Lili, et al.
Publicado: (2020)